Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports

[1]  D. Choi,et al.  Amiodarone toxicity showing high liver density on CT scan with normal liver function and plasma amiodarone levels in a long-term amiodarone user. , 2014, International journal of cardiology.

[2]  N. Hussain,et al.  Amiodarone-Induced Cirrhosis of Liver: What Predicts Mortality? , 2013, ISRN cardiology.

[3]  M. Shoda,et al.  Amiodarone-Induced thyroid dysfunction and ventricular tachyarrhythmias during long-term therapy in Japan. , 2001, Japanese circulation journal.

[4]  N. Goldschlager,et al.  Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. , 2000, Archives of internal medicine.

[5]  M. Richer,et al.  Fatal Hepatotoxicity Following Oral Administration of Amiodarone , 1995, The Annals of pharmacotherapy.

[6]  J J Heger,et al.  Clinical features of amiodarone-induced pulmonary toxicity. , 1990, Circulation.

[7]  T. Vilén,et al.  Mechanism of phospholipidosis in amiodarone pulmonary toxicity. , 1989, The Journal of pharmacology and experimental therapeutics.

[8]  K. Ishak,et al.  Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients , 1989, Hepatology.

[9]  P. Armstrong,et al.  Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues. , 1987, Canadian journal of physiology and pharmacology.

[10]  Randy M. Perse,et al.  Histopathologic analysis of suspected amiodarone hepatotoxicity. , 1990, Human pathology.

[11]  J. Mason.  Drug therapy: amiodarone , 1987 .